Edition:
United Kingdom

Prothena Corporation PLC (PRTA.OQ)

PRTA.OQ on NASDAQ Stock Exchange Global Select Market

38.62USD
7:21pm GMT
Change (% chg)

$-1.42 (-3.55%)
Prev Close
$40.04
Open
$40.03
Day's High
$40.12
Day's Low
$38.50
Volume
56,485
Avg. Vol
111,240
52-wk High
$70.00
52-wk Low
$38.01

Latest Key Developments (Source: Significant Developments)

Prothena reports Q3 loss per share $1.37
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Prothena Corporation Plc ::Prothena reports third quarter 2017 financial results and provides research and development update.Q3 loss per share $1.37.Q3 revenue $200,000.Q3 revenue view $251,000 -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-1.39 -- Thomson Reuters I/B/E/S.  Full Article

Prothena reports third quarter financial results
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Prothena Corporation Plc :Prothena reports third quarter 2017 financial results and provides research and development update.Q3 loss per share $1.37.Q3 revenue $200,000.Q3 revenue view $251,000 -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-1.39 -- Thomson Reuters I/B/E/S.  Full Article

Prothena reports Q4 loss per share $1.41
Tuesday, 14 Feb 2017 

Prothena Corporation Plc : Prothena Corporation Plc - Company expects full year 2017 net cash burn from operating and investing activities to be $160 to $170 million . Prothena reports fourth quarter and full year 2016 financial results, and provides financial guidance and research and development update . Q4 loss per share $1.41 . Q4 revenue $200,000 . Q4 revenue view $5.4 million -- Thomson Reuters I/B/E/S . Q4 earnings per share view $-1.12 -- Thomson Reuters I/B/E/S .Prothena Corporation Plc - Estimated 2017 net cash burn from operating, investing activities is primarily driven by estimated net loss of $177 to $191 million.  Full Article

Prothena Q4 loss per share $1.41
Tuesday, 14 Feb 2017 

Prothena Corporation Plc : Prothena corporation plc - expects full year 2017 net cash burn from operating and investing activities to be $160 to $170 million . Prothena reports fourth quarter and full year 2016 financial results, and provides financial guidance and research and development update . Q4 loss per share $1.41 . Q4 revenue $200,000 . Q4 revenue view $5.4 million -- Thomson Reuters I/B/E/S . Q4 earnings per share view $-1.12 -- Thomson Reuters I/B/E/S .Prothena corporation plc - estimated net loss of $177 to $191 million for fy.  Full Article

Prothena appoints Dr. Gene G. Kinney as CEO
Monday, 3 Oct 2016 

Prothena Corporation Plc : Prothena announces appointment of Dr. Gene G. Kinney as president, chief executive officer and director .Appointments come following passing of Prothena's co-founder, President and CEO, Dale B. Schenk.  Full Article

Prothena Corporation - CEO Dale B. Schenk, passed away
Friday, 30 Sep 2016 

Prothena Corporation Plc : Says Co-Founder, President and Chief Executive Officer, Dr. Dale B. Schenk, passed away .Says Board is meeting shortly regarding succession and an announcement will follow.  Full Article

Prothena says CEO Dr. Dale Schenk to take medical leave
Monday, 26 Sep 2016 

Prothena Corporation Plc : Prothena announces president and CEO Dr. Dale B. Schenk to take medical leave . Says Schenk will continue serving on Prothena's board of directors .Says co will be led by Gene Kinney.  Full Article

Prothena reports Net loss per share for Q2 $1.18
Tuesday, 2 Aug 2016 

Prothena Corporation Plc : Prothena reports second quarter 2016 financial results; provides research and development update . Net loss per share for q2 $1.18 . Projected full year 2016 net cash burn from operating and investing activities to be $118 to $128 million . Total revenue of $0.3 million for q2 compared to total revenue of $0.3 million for q2 of 2015 .Q2 earnings per share view $-0.91, revenue view $335710.00 -- Thomson Reuters I/B/E/S.  Full Article

Prothena Q2 loss per share $1.18
Tuesday, 2 Aug 2016 

Prothena Corporation Plc : Prothena reports second quarter 2016 financial results; provides research and development update .Q2 loss per share $1.18.  Full Article

Prothena Corporation PLC announces pricing of public offering of 2,250,000 ordinary shares
Thursday, 7 Jan 2016 

Prothena Corporation PLC:Says priced an underwritten public offering of 2,250,000 of its ordinary shares at a price to the public of $53.00 per ordinary share.Net proceeds to Prothena from the ordinary shares to be sold by Prothena in the offering are expected to be $111.8 million.  Full Article

Short seller Kerrisdale targets Woodford-backed Prothena

LONDON Hedge fund Kerrisdale Capital has taken a short position in drugmaker Prothena , a company backed by UK investor Neil Woodford, calling it "the next big biotech blowup".